Risa Hamada
Odawara, 2508588, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Survey of Awareness of End-of-Life Care among University Students: A Comparison between Medical and Welfare Disciplines.
Journal: Journal of cancer education : the official journal of the American Association for Cancer Education
Published: January 30, 2026
Survey on attitudes toward end-of-life care among third-year students in the faculty of physical therapy: a study across the first and second semesters.
Journal: Journal of physical therapy science
Published: November 13, 2025
Author reply to the letter regarding 'Dietary habits in adult Japanese patients with vitiligo'.
Journal: The Journal of dermatology
Published: March 25, 2024
Sustained Effectiveness of Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A 48-Week Real-World Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 17, 2024
Effectiveness of Dose Increase in Upadacitinib from 15 mg to 30 mg for Patients with Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice in Japan.
Journal: Clinical drug investigation
Published: February 25, 2024
Predictive factors for responders to upadacitinib treatment in patients with atopic dermatitis.
Journal: The Journal of dermatological treatment
Published: February 01, 2024
Dietary habits in adult Japanese patients with vitiligo.
Journal: The Journal of dermatology
Published: January 23, 2024
Total eosinophil count as a biomarker for therapeutic effects of upadacitinib in atopic dermatitis over 48 weeks.
Journal: Frontiers in immunology
Published: January 08, 2024
Effectiveness of switching from baricitinib 4 mg to upadacitinib 30 mg in patients with moderate-to-severe atopic dermatitis: a real-world clinical practice in Japan.
Journal: The Journal of dermatological treatment
Published: December 11, 2023
Early itch relief with upadacitinib predicts later skin clearance in Atopic dermatitis.
Journal: The Journal of dermatological treatment
Published: December 11, 2023
Effectiveness and Safety of Upadacitinib in Combination with Topical Corticosteroids in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis.
Journal: Clinical, cosmetic and investigational dermatology
Published: September 07, 2023
Therapeutic effectiveness of upadacitinib on individual types of rash in Japanese patients with moderate-to-severe atopic dermatitis.
Journal: The Journal of dermatology
Published: June 15, 2023
Last Updated: 09/26/2026